37.5 F
New York
Friday, January 22, 2021

Moderna Inc. [NASDAQ: MRNA] Announces Modification To Its BARDA Agreement

Must read

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...

Shutterstock [NYSE: SSTK] To Extend Its Agreement With EPA

Shutterstock reported that the company renewed its exclusive contract with the European Pressphoto Agency. The extended contract is to distribute the visual content...

Moderna Inc. [NASDAQ: MRNA] has announced Sunday that it has changed its contract with Biomedical Advanced Research and Development Authority (BARDA). According to the modification, it has received an additional commitment of $472 million to aid the late clinical-stage development including the expanded Phase 3 study of the company’s mRNA vaccine candidate (mRNA-1273) against COVID-19.

Earlier, BARDA has awarded up to $483 million to help the clinical development and mRNA-1273 with a small number of participants in phase 3 clinical trial. After consultation with the US Food and Drug Administration (FDA) and Operation Wrap Speed, Moderna Inc has decided to conduct a larger Phase 3 clinical trial.

After this modification in contract with BARDA the additional payment help company to conduct the phase 3 trial with 30,000 participants. The total investment from BARDA is now valued at $955 million.

Shares of Moderna Inc. dropped 2.81% during the trading of Friday. The company has a closing price of $73.21. It has a trading volume of 27.7 million as compared to the average volume of 25.91 million.

If we turn our focus on profitability, it has return on assets (ROA) of -29.20%, return on equity (ROE) of -37.40% and return on investment (ROI) of -44.90%. Looking at its liquidity, this company has a current and quick ration of 9.30.

In the past 52-weeks of trading, its stocks have oscillated between the low of $11.54 and a high of $95.21. It has moved up 534.40% from its 52-weeks low and moved down -23.11% from 52-weeks high. Moderna Inc has recorded the sales of 52.60 million and has a market cap of 29.21 billion.

Stéphane Bancel, Moderna’s Chief Executive Officer has expressed gratitude to BARDA for the support in the trial of the coronavirus vaccine candidates. Moderna Inc phase 3 COVE study will begin from tomorrow July 27 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID).

FDA has checked the phase 3 stuy protocol and its process is same as according to the FDA guidance for COVID-19 vaccine. mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein. It was selected by Moderna Inc in collaboration with investigators from the VRC.

More articles

Latest article

Tencent Music [NYSE: TME] To Purchase 100% Equity Interest Of Lazy Audio

Tencent Music Entertainment Group reported that the company has signed a contract to purchase 100 percent shares of Lazy Audio. Lazy audio is...

Desktop Metal [NYSE: DM] Inks Agreement To Purchase EnvisionTEC

Desktop Metal reported that the company inked a definitive contract to purchase EnvisionTEC. Desktop Metal will purchase EnvisionTEC for a total consideration of...

Sequential Brands [NASDAQ: SQBG] Partnered With Omega Apparel To Create A New Collection

Sequential Brands Group reported that the company has collaborated with Omega Apparel for its denim business. With this partnership, the company will develop...

Marathon Petroleum [NYSE: MPC] Appoints New CFO

Marathon Petroleum Corp. reported that the company has named Maryann T. Mannen as the CFO and Executive V.P of the company. Maryann has...

QUALCOMM [NASDAQ: QCOM] Announces To Purchase NUVIA For $1.4Billion

QUALCOMM Incorporated reported that its unit, Qualcomm technologies inked a contract to purchase NUVIA.  The company will purchase NUVIA for nearly $1.4B. The...

Trivago [NASDAQ: TRVG] Reported The Purchase Of Weekend.com

Trivago reported that the company has purchased Weekend.com. Weekend it just started based in Germany, its main aim is to provide stimulating getaway...

Arthur J. Gallagher [NYSE: AJG] Reports To Purchase 100% of The Bollington Wilson Group

Arthur J. Gallagher reported that the company has inked a contract to buy 100% of the Bollington Wilson group. Bollington is an insurance...

Grainger [NYSE: GWW] Reports Changes In The Executive Leadership

Grainger reported changes in its Executive leadership. The leading supplier and distributor of MRO products appointed Deidra Merriwether as the Chief Financial officer....